SEMASLIM 0.25 INJ. contains Semaglutide 0.25 mg. It is a GLP-1 receptor agonist medicine used to improve blood sugar control and support weight management in eligible patients.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Helps improve blood glucose control along with diet and exercise
-
Reduces the risk of major cardiovascular events in certain patients with type 2 diabetes and cardiovascular risk
-
Supports weight management in eligible patients (as prescribed)
Dose:
-
Adults: Usually started with 0.25 mg once weekly as an initial dose, as directed by a physician
-
Administered by subcutaneous injection under medical guidance
-
Inject on the same day each week, with or without meals
-
Dose may be increased gradually depending on the patient’s condition and response to treatment
-
Follow the prescribed dose and duration as advised by a healthcare professional